l carnitine and kidneg disease Combined protective effects of oligo-fucoidan, fucoxanthin, L-carnitine on the kidneys of chronic kidney mice The adverse effects of long-term

Antidepressants with serotonin reuptake inhibition effect (SSRI, SNRI, amitriptyline (the most used TCA)) increased the risk of certain organ-specific defects: paroxetine increased the risk of cardiac defects (aOR 1.45, 95% CI 1.12 to 1.88), and ventricular/atrial septal defects (aOR 1.39, 95% CI 1.00 to 1.93)

1 Exposing these cells to a low-glucose medium with 0.1 nM insulin for 5 days increases their insulin sensitivity, resulting in a physiological insulin dose response in AKT2 phosphorylation, insulin-stimulated glucose uptake, GLUT4 translocation, and suppression of lipolysis

Emerging hepatoprotective agents Hepatoprotective agents have been explored to counteract drug-induced liver injury from psoriasis drugs

Introduction The search for a brighter, more even complexion often leads to one specific molecule: glutathione